Literature DB >> 10440931

Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro.

L Malaval1, F Liu, P Roche, J E Aubin.   

Abstract

Fetal rat calvaria cells plated at very low density generate discrete colonies, some of which are bone colonies (nodules) from individual osteoprogenitors that divide and differentiate. We have analyzed the relationship between cell proliferation and acquisition of tissue-specific differentiation markers in bone colonies followed individually from the original single cell to the fully mineralized state. The size distribution of fully formed nodules is unimodal, suggesting that the coupling between proliferation and differentiation of osteoprogenitor cells is governed by a stochastic element, but distributed around an optimum, corresponding to the peak colony size/division potential. Kinetic analysis of colony growth showed that osteoprogenitors undergo 9-10 population doublings before the appearance of the first morphologically differentiated osteoblasts in the developing colony. Double immunolabeling showed that these proliferating cells express a gradient of bone markers, from proliferative alkaline phosphatase-negative cells at the periphery of colonies, to postmitotic, osteocalcin-producing osteoblasts at the centers. An inverse relationship exists between cell division and expression of osteocalcin, the latter being restricted to late-stage, BrdU-negative osteoblasts, while the expression of all other markers is acquired before the cessation of proliferation, but not concomitantly. Bone sialoprotein expression is biphasic, detectable in some of the early, alkaline phosphatase-negative cells, and again later in both late preosteoblast (BrdU-positive) and osteoblast (BrdU-negative, osteocalcin-positive) cells. In late-stage, heavily mineralized nodules, staining for osteocalcin and bone sialoprotein is not detectable in the oldest/most mature cells. Our observations support the view that the bone nodule "tissue-like" structure, originating from a single osteoprogenitor and finally encompassing mineralized matrix production, recapitulates successive stages of the osteoblast differentiation pathway, in a proliferation/maturation sequence. Understanding the complexity of the proliferation/differentiation kinetics that occurs within bone nodules will aid in the qualitative and/or quantitative interpretation of tissue-specific marker expression during osteoblastic differentiation. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10440931

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  41 in total

1.  Interactions between endothelial progenitor cells (EPC) and titanium implant surfaces.

Authors:  Thomas Ziebart; Anne Schnell; Christian Walter; Peer W Kämmerer; Andreas Pabst; Karl M Lehmann; Johanna Ziebart; Marc O Klein; Bilal Al-Nawas
Journal:  Clin Oral Investig       Date:  2012-03-10       Impact factor: 3.573

2.  The growth and morphogenesis of the early mouse mandible: a quantitative analysis.

Authors:  Thaya Ramaesh; Jonathan B L Bard
Journal:  J Anat       Date:  2003-08       Impact factor: 2.610

3.  Chitosan enhances mineralization during osteoblast differentiation of human bone marrow-derived mesenchymal stem cells, by upregulating the associated genes.

Authors:  S Mathews; P K Gupta; R Bhonde; S Totey
Journal:  Cell Prolif       Date:  2011-10-20       Impact factor: 6.831

4.  Mesenchymal stem cells and tissue engineering.

Authors:  Nicholas W Marion; Jeremy J Mao
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

5.  Correlative spectroscopy of silicates in mineralised nodules formed from osteoblasts.

Authors:  Suwimon Boonrungsiman; Sarah Fearn; Eileen Gentleman; Liam Spillane; Raffaella Carzaniga; David W McComb; Molly M Stevens; Alexandra E Porter
Journal:  Nanoscale       Date:  2013-08-21       Impact factor: 7.790

6.  Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice.

Authors:  M P Macias; L A Fitzpatrick; I Brenneise; M P McGarry; J J Lee; N A Lee
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 7.  "Ins" and "Outs" of mesenchymal stem cell osteogenesis in regenerative medicine.

Authors:  Dean T Yamaguchi
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

8.  In vitro biocompatibility assessment of PHBV/Wollastonite composites.

Authors:  Haiyan Li; Wanying Zhai; Jiang Chang
Journal:  J Mater Sci Mater Med       Date:  2007-06-19       Impact factor: 3.896

9.  A subset of osteoblasts expressing high endogenous levels of PPARgamma switches fate to adipocytes in the rat calvaria cell culture model.

Authors:  Yuji Yoshiko; Kiyoshi Oizumi; Takuro Hasegawa; Tomoko Minamizaki; Kazuo Tanne; Norihiko Maeda; Jane E Aubin
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

10.  Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling.

Authors:  Anne M Delany; Kurt David Hankenson
Journal:  J Cell Commun Signal       Date:  2009-10-28       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.